review of glp 1 Glucagon-like peptide-1 receptor agonists and risk gastrointestinal cancers: A systematic and meta-analysis of randomized controlled trials Frontiers | GLP-1 Receptor Agonists:

Once-Weekly Semaglutide in Adolescents with Obesity

Pflugers Arch Eur J Physiol 460(1):6976

Thats too bad, since theyre high in fibre, which boosts overall health

You want to minimize how much nausea, fatigue, and GI effects interfere with your daily life

At UAB, scientists are working to understand not just that these medications work, but how they work: how they act in the brain, how they affect multiple organs at once, why some patients respond better than others and what next-generation versions of these drugs might look like

Regulatory & Approval Risks Navigating the regulatory environment is a challenge in developing weight loss drugs